Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
CAP1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
HHLA3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
GPR135 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SGSM1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SLC4A7 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GYG2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SSBP3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
GPR68 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
C11orf70 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
IVNS1ABP - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ERCC8 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC101929260 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LIMCH1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SETD3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
BHLHE41 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PLAU - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ARL17B - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on